Noninvasive identification of HER2-zero, -low, or -overexpressing breast cancers: Multiparametric MRI-based quantitative characterization in predicting HER2-low status of breast cancer

•SyMRI accurately determined the HER2 status of individuals with breast cancer, particularly those with low expression levels of HER2.•The PDe is superior to the conventional quantitative indicator in HER2 expression discrimination.•The quantitative indicator PDe may be an alternative marker suitabl...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of radiology 2024-08, Vol.177, p.111573, Article 111573
Hauptverfasser:	Zhan, Ting, Dai, Jiankun, Li, Yan
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Human epidermal growth factor receptor 2 Synthetic magnetic resonance imaging
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!